Log in to save to my catalogue

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic...

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fce45e0fad7140b198d15186ffc940b3

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

About this item

Full title

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2016-02, Vol.14 (1), p.10-11, Article 10

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the evidence to support such withdrawals, and explored the pattern of withdrawals across countries.
We sea...

Alternative Titles

Full title

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fce45e0fad7140b198d15186ffc940b3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fce45e0fad7140b198d15186ffc940b3

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-016-0553-2

How to access this item